NeoGenomics Buys Ex-Novartis Cancer Lab Genoptix for $125M, Stock
Xconomy
OCTOBER 23, 2018
The buyout comes almost two years after Carlsbad, CA-based Genoptix was bought from Novartis (NYSE: NVS ) by a pair of private investment firms, Ampersand Capital Partners and 1315 Capital, and a management group for an undisclosed sum in January 2017. Joseph Limber became the CEO of the company.
Let's personalize your content